Mariner
NUVB icon

Mariner’s Nuvation Bio NUVB Stock Holding History

Mariner’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$238K Buy
55,401
+1,288
+2% +$7.17K ﹤0.01% 3055
2025
Q4 		$485K Sell
54,113
-4,297
-7% -$26.6K ﹤0.01% 2463
2025
Q3 		$216K Buy
58,410
+45,466
+351% +$124K ﹤0.01% 3109
2025
Q2 		$25.2K Buy
+12,944
New +$27K ﹤0.01% 3401
2023
Q4 		– Sell
-26,795
Closed -$35.9K – 3140
2023
Q3 		$35.9K Buy
+26,795
New +$44.6K ﹤0.01% 2805

Other funds holding NUVB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
DFO
Duquesne Family Office New York $3.38B AUM 61.92% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Mariner's NUVB Position: Q1 2026 in Review

Mariner increased its Nuvation Bio (NUVB) stake by 2.4% in Q1 2026, buying an estimated $7.17K and bringing the position to 55,401 shares worth $238K. The position accounts for ﹤0.01% of the portfolio, ranked #3055.

Mariner first reported a position in NUVB in Q3 2023 and has held it in 5 quarters since. The position peaked at $485K in Q4 2025. 231 funds tracked by Wall St. Rank hold NUVB as of Q1 2026.

  • Mariner held 55,401 shares of Nuvation Bio worth $238K as of Q1 2026.
  • Mariner bought 1,288 Nuvation Bio shares in Q1 2026, an estimated $7.17K.
  • Nuvation Bio made up ﹤0.01% of Mariner's portfolio in Q1 2026, its #3055 holding.
  • Mariner first reported a position in Nuvation Bio in Q3 2023 and has held it in 5 quarters since.
  • Mariner's Nuvation Bio position peaked at $485K in Q4 2025.
  • 231 funds tracked by Wall St. Rank held Nuvation Bio as of Q1 2026.

Based on Mariner's 13F filing for Q1 2026, filed 13 May 2026.